Healthcare Regulation (HIPAA)

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

Wellness brand Le-Vel is launching a telehealth service for prescription peptides, blurring the lines between direct sales and mainstream medicine.

ITG Brands acquires innovator Black Buffalo for $150M, diversifying beyond nicotine pouches to capture a new segment of smokeless alternative users.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

Positive Phase 3 data for oral drug filgotinib offers new hope for thousands of axial spondyloarthritis patients who fail to respond to current therapies.

A Texas court's dismissal of a BCBS lawsuit is the latest ruling strengthening patient protections and the binding arbitration at the heart of the law.

Asset Workflows secures major funding to expand its data management solutions into the APAC region and the highly regulated healthcare sector.

A new E. coli outbreak linked to The Kebab Shop sickens nine, raising questions about ground beef safety and echoing a decades-long battle for reform.

One of only two in Florida, ECW Network & IT Solutions passes a grueling cyber audit, setting a new benchmark for business security and compliance.

As AI floods classrooms, one firm has launched a major initiative, backed by a tech giant's grant, to help schools navigate bias, privacy, and equity.

With new funding from Bregal Sagemount, LSPedia is set to advance its AI tools, moving beyond compliance to build a smarter, safer pharma supply chain.

ValGenesis's upcoming event explores AI's pivotal role in pharma validation, charting a course from digital systems to intelligent, compliant operations.

A new analysis reveals most insured Americans can't access obesity drugs, even with coverage, due to restrictive insurance hurdles.

A Chinese firm services ultrasound machines in 140+ countries, challenging OEM dominance and helping hospitals cut costs and extend equipment life.

A new report reveals Europe's medically-focused cannabis market is finally waking, creating a new global blueprint but also intense competition and price wars.

A skincare brand is challenging the FDA over sunscreen ingredients, revealing decades of regulatory delay and raising questions about what’s safe for our skin.

A new report shows hospitals in a federal drug discount program provide less charity care than others, fueling calls for urgent federal reforms.

A new telehealth platform offers prescription-only CBD, navigating a major regulatory shift that will reshape the entire cannabis industry. Here's what's next.

Cannabis giant Curaleaf is rolling the dice with a reverse stock split, aiming for a coveted spot on a major U.S. exchange ahead of federal rescheduling.

With strong clinical data for its Dayspring system, Koya Medical is pitching to investors to fund the next phase of growth for its patient-centered tech.